Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:57 pm Sale | 2023-12-31 | 13G | Turtle Beach Corporation TBCH | CITADEL ADVISORS LLC | 223,036 1.300% | -683,735 (-75.40%) | Filing History |
| 2024-02-14 4:57 pm Sale | 2023-12-31 | 13G | Appian Corporation APPN | CITADEL ADVISORS LLC | 1,372,895 3.300% | -584,302 (-29.85%) | Filing History |
| 2024-02-14 4:55 pm Sale | 2023-12-31 | 13G | Forbion European Acquisition Corp. FRBN | CITADEL ADVISORS LLC | 0 0.000% | -1,075,058 (Position Closed) | Filing History |
| 2024-02-14 4:55 pm Sale | 2023-12-31 | 13G | Khosla Ventures Acquisition Co. KVSA | CITADEL ADVISORS LLC | 0 0.000% | -2,705,290 (Position Closed) | Filing History |
| 2024-02-14 4:55 pm Sale | 2023-12-31 | 13G | Acropolis Infrastructure Acquisition Corp. ACRO | CITADEL ADVISORS LLC | 0 0.000% | -2,241,549 (Position Closed) | Filing History |
| 2024-02-14 4:55 pm Sale | 2023-12-31 | 13G | Apollo Strategic Growth Capital II APGB | CITADEL ADVISORS LLC | 0 0.000% | -4,078,643 (Position Closed) | Filing History |
| 2024-02-14 4:55 pm Sale | 2023-12-31 | 13G | Artemis Strategic Investment Corporation ARTE | CITADEL ADVISORS LLC | 0 0.000% | -1,621,525 (Position Closed) | Filing History |
| 2024-02-14 4:55 pm Sale | 2023-12-31 | 13G | Decibel Therapeutics, Inc. DBTX | CITADEL ADVISORS LLC | 0 0.000% | -1,863,411 (Position Closed) | Filing History |
| 2024-01-22 4:04 pm Purchase | 2024-01-12 | 13G | NETSTREIT Corp. NTST | CITADEL ADVISORS LLC | 4,108,199 5.200% | 4,108,199 (New Position) | Filing History |
| 2024-01-02 4:14 pm Purchase | 2023-12-20 | 13G | COMPASS Pathways plc CMPS | CITADEL ADVISORS LLC | 3,195,517 5.000% | 3,195,517 (New Position) | Filing History |
| 2023-12-26 4:47 pm Purchase | 2023-12-15 | 13G | Allurion Technologies Inc. ALUR | CITADEL ADVISORS LLC | 102,285 5.100% | 102,285 (New Position) | Filing History |
| 2023-12-15 4:01 pm Purchase | 2023-12-05 | 13G | Blink Charging Co. BLNK | CITADEL ADVISORS LLC | 610,671 0.900% | 610,671 (New Position) | Filing History |
| 2023-11-20 4:37 pm Purchase | 2023-11-08 | 13G | Turtle Beach Corporation TBCH | CITADEL ADVISORS LLC | 906,771 5.200% | 906,771 (New Position) | Filing History |
| 2023-11-17 5:12 pm Purchase | 2023-11-07 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | CITADEL ADVISORS LLC | 3,839,829 5.400% | 2,335,959 (+155.33%) | Filing History |
| 2023-11-17 4:23 pm Purchase | 2023-11-07 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | CITADEL ADVISORS LLC | 2,092,488 8.300% | 2,092,488 (New Position) | Filing History |
| 2023-11-17 4:21 pm Purchase | 2023-11-07 | 13G | Appian Corporation APPN | CITADEL ADVISORS LLC | 1,957,197 4.700% | 1,957,197 (New Position) | Filing History |
| 2023-11-13 4:41 pm Purchase | 2023-11-01 | 13G | VYNE Therapeutics Inc. VYNE | CITADEL ADVISORS LLC | 1,181,167 8.500% | 1,181,167 (New Position) | Filing History |
| 2023-11-13 4:34 pm Purchase | 2023-11-03 | 13G | Korro Bio, Inc. KRRO | CITADEL ADVISORS LLC | 546,218 6.800% | 546,218 (New Position) | Filing History |
| 2023-11-06 4:34 pm Purchase | 2023-10-25 | 13G | Harpoon Therapeutics, Inc. HARP | CITADEL ADVISORS LLC | 1,027,959 6.000% | 1,027,959 (New Position) | Filing History |
| 2023-10-26 4:01 pm Purchase | 2023-10-16 | 13G | Groupon, Inc. GRPN | CITADEL ADVISORS LLC | 1,344,504 4.300% | 1,344,504 (New Position) | Filing History |